Get the Stockscreener App
7.22
0.84%
0.06
After Hours:
3.43
-3.79
-52.49%
Mimedx Group Inc stock is traded at $7.22, with a volume of 643.66K.
It is up +0.84% in the last 24 hours and down -3.48% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$7.16
Open:
$7.2
24h Volume:
643.66K
Relative Volume:
0.77
Market Cap:
$1.07B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
11.75
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
+4.18%
1M Performance:
-3.48%
6M Performance:
+17.97%
1Y Performance:
-23.52%
1-Day Range:
$7.10
$7.295
1-Week Range:
$6.66
$7.295
52-Week Range:
$5.79
$9.71
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.66 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.30 | 268.44M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.14 | 223.06M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.7287 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.74 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
Divisadero Street Capital Management LP Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
Trigran Investments Inc. Has $51.27 Million Holdings in MiMedx Group, Inc $MDXG - MarketBeat
Why MiMedx Group Inc. stock remains undervaluedWeekly Trade Analysis & Proven Capital Preservation Tips - Newser
How currency fluctuations impact MiMedx Group Inc. stockJuly 2025 Rallies & Intraday High Probability Alerts - Newser
Can MiMedx Group Inc. stock maintain operating margins2025 Dividend Review & Precise Swing Trade Alerts - BỘ NỘI VỤ
MiMedx announces publication of interim results from CAMPAIGN trial - MSN
Will MiMedx Group Inc. stock gain from lower inflationTrade Exit Summary & Growth Oriented Trading Recommendations - BỘ NỘI VỤ
MiMedx Group Inc. Reports Record Q3 Revenue - MSN
MiMedx Group (MDXG) Is Down 8.4% After Strong CAMPAIGN Trial Results for EPIEFFECT Product – What's Changed - simplywall.st
Is MiMedx Group Inc. stock attractive for long term wealth building - newser.com
Is MiMedx Group Inc. stock a good choice for value investors2025 Retail Activity & Weekly Stock Breakout Alerts - newser.com
Will MiMedx Group Inc. stock maintain dividend yieldFed Meeting & Smart Money Movement Tracker - newser.com
Can MiMedx Group Inc. stock sustain market leadershipJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Is MiMedx Group Inc. showing signs of accumulationVolume Spike & Pattern Based Trade Signal System - newser.com
Will MiMedx Group Inc. stock go up soon2025 Historical Comparison & Risk Managed Trade Strategies - newser.com
Will MiMedx Group Inc. stock recover faster than peersJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
MiMedx Group (NASDAQ:MDXG) Stock Price Down 5.6%What's Next? - MarketBeat
How Mimedx Group Inc (MDXG) Affects Rotational Strategy Timing - news.stocktradersdaily.com
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Is MiMedx Group Inc. stock attractive for ETFsBond Market & AI Driven Price Forecasts - newser.com
Using data models to predict MiMedx Group Inc. stock movement2025 Big Picture & Technical Buy Zone Confirmations - newser.com
What indicators show strength in MiMedx Group Inc.July 2025 PostEarnings & Daily Price Action Insights - newser.com
Is MiMedx Group Inc. stock a safe investment in uncertain marketsJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - newser.com
Is MiMedx Group Inc. stock attractive for retirement portfoliosRate Cut & Weekly Consistent Profit Watchlists - Fundação Cultural do Pará
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):